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in the IAEA database (http://mvgs.iaea.org/Search.
aspx) obtained via chemical mutagenesis were induced 
by alkylating agents. Of these, three compounds are 
significant: ethyl methanesulphonate (EMS), 1-methyl-
1-nitrosourea (MNU) and 1-ethyl-1-nitrosourea (ENU), 
which account for 64% of these varieties (Figure 12.1).
2. Alkylating Agents
2.1. Sources and Types of Alkylating Agents
Alkylating agents are strong mutagenic, carcinogenic 
and cytotoxic compounds (Figure 12.2). Paradoxically, 
the cytotoxic properties of some of the compounds are 
largely exploited in cancer therapy. Alkylating agents 
can be found among a large panoply of classes of 
compounds, including sulphur mustards, nitrogen mus-
tards, epoxides, ethyleneimines and ethyleneimides, 
alkyl methanesulphonates, alkylnitrosoureas, alkylni-
trosoamines, alkylnitrosoamides, alkyl halides, alkyl 
sulphates, alkyl phosphates, chloroethyl sulphides, 
chloroethylamines, diazoalkanes, etc.  
Although most are synthetically produced, a few 
alkylating agents are of biological origin, e.g.  the strong 
mutagenic glucosamine-nitrosourea (Streptozotocin) is 
produced by Streptomyces achromogenes. 
Figure 12.1  Relative number of released mutant varieties (direct and indirect)  induced using the agents indicated. EMS – ethyl methanesul-
phonate; ENU – 1-ethyl-1-nitrosourea; MNU – 1-methyl-1-nitrosourea; EI – ethyleneimine; DMS – dimethyl sulphate;  DES – diethyl sulphate; 
Colch – colchicine; NaN3 – sodium azide.
1. Introduction
The first attempts to induce mutations in biological 
systems using chemical compounds go back to the 
beginning of the past century. However, it was during 
World War II that the two most relevant names in 
chemical mutagenesis, Charlotte Auerbach and Iosif 
A. Rapoport, established the mutagenic properties of 
several chemical compounds (Box 12.1). A detailed 
review of these and other major moments in the history 
of plant chemical mutagenesis is given by van Harten 
(1998, see Chapters 1 and 2).
There is currently an enormous number of known 
chemical compounds able to induce mutations in 
prokaryotic and/or eukaryotic cells and this continues 
to increase. The continuous search and the synthesis of 
new mutagenic compounds is driven, not by the needs 
of experimental mutagenesis, but by the paradoxal fact 
that several mutagenic compounds, although carcino-
genic, possess simultaneously anti-neoplastic proper-
ties and find application in anti-tumour therapy.
Despite the large number of mutagenic compounds, 
only a small number has been tested in plants. Among 
them, only a very restricted group of alkylating agents 
has found large application in plant experimental 
mutagenesis and plant mutation breeding. Over 80% 
of the registered new mutant plant varieties reported 
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Some alkylating agents such as the methyl-donor 
S-adenosylmethionine (SAM), which in spite of being 
involved in about 40 metabolic reactions in mammali-
ans is a weak methylating agent able to form adducts to 
DNA, are formed endogenously as natural products of 
organisms. Other alkylating agents such as chlorometh-
ane (CH3Cl), formerly thought to be uniquely of ocean 
origin but today assumed to have a dominant terrestrial 
origin as result of the reaction of plant pectin with chlo-
ride, are naturally formed in the environment. A signifi-
cant source of environmental exposure of humans to 
alkylating compounds, particularly to the carcinogenic 
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), 
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) 
and N’-nitrosonornicotine (NNN), is tobacco smoke.
Alkylating agents are electrophilic compounds with 
affinity for nucleophilic centres in organic macro-
molecules to which they bind covalently. In DNA these 
compounds form covalently linked alkyl adducts to the 
bases and to the phosphodiesters.
Box 12.1: C. Auerbach and I. Rapport and their work on chemical mutagenesis
Charlotte Auerbach (1899–1994) was born to a Jewish family in Krefeld, Germany. She attended classes at the Universities of Berlin, 
Würzburg and Freiburg. After her “State examination” in 1924 and a short period of research in developmental biology she spent some 
years teaching at various schools in Berlin.  After Hitler became the German Chancellor and new laws prohibited Jews from teaching in state 
schools she moved to the UK. There, through Professors H. Freundlich and G. Barger, she was introduced to F.A.E. Crew, head of the Institute 
of Animal Genetics in Edinburgh, where she started to work on Drosophila and was awarded a Ph.D. in 1935. In 1939 she acquired British 
citizenship, thus avoiding incarceration in internment camps during the second World War. 
In 1938 Crew introduced Auerbach to H.J. Müller who stimulated her to test a number of chemical agents known to be carcinogenic for 
induction of mutations in Drosophila. After obtaining negative results with 1:2:5:6-dibenzanthracene, 9:10-dimethyl-1:2 dibenzanthracene 
and methyl-colanthrene, in 1940 Auerbach began to work in collaboration with J.M. Robson on the mutagenic effects of mustard gas. 
Robson had at that time already observed the antimitotic effect of this compound in the vaginal ephithelium of rats. During their col-
laboration most of the experimental treatments were carried out by Robson and his collaborators, while Auerbach performed the genetic 
analysis of treated Drosophila using the ClB method introduced by Müller, with whom she discussed experimental results. 
In 1942, Auerbach and Robson sent several reports to the Ministry of Supply of the British Government where they described the induc-
tion of sex-linked lethal, chromosomes inversions and translocations by mustard gas (encrypted as substance “H”). They also reported mus-
tard gas to act directly on the chromosomes while describing the induced visible mutations and discussing the similarities and dissimilarities 
of the effects of this chemical mutagen and those of X-rays.
In a letter to Nature in 1944, Auerbach and Robson mentioned that they had tested a number of chemical substances for their ability to 
produce mutations and that some of them were very effective, producing mutation rates of the same order as those with X-rays. However, 
it was not until 1946 in a new letter to Nature that the name of the mutagenic substance, dichloro-diethyl-sulphide or mustard gas, was 
disclosed.  According to Auerbach the idea of testing mustard gas was suggested by the pharmacologist A.J. Clark who saw similarities 
between the long-lasting effects of this compound and that of X-rays, and hypothesized mustard gas to have effects on the genetic material. 
Auerbach kept working in the field of mutagenesis, even long after she retired, publishing several articles and some major books, some 
of them translated into multiple languages. She was honoured with many prizes and distinctions including the Darwin Medal by the Royal 
Society in 1977. 
Iosif Abramovich Rapoport (1912–1990)  was born in Chernigov, Ukraine. In 1930 he started his studies at the Faculty of Biology at the 
Leningrad State University and in 1938 he was awarded a Ph.D. in biological sciences by the Institute of Genetics of the Academy of Sciences. 
A Doctor of Sciences degree was awarded in 1943 after he defended his thesis and while attending a rapid course for commanders at the 
Frunze Military Academy in Moscow.
Twice injured during the war (he lost an eye) Rapoport was awarded many major military medals of the Soviet Union and the USA Legion 
of Merit. After the war he resumed his research at the Institute of Cytology, Histology and Embryology in Moscow, working on chemical 
mutagenesis in Drosophila. 
Although the first mutants induced by chemical mutagenesis were probably identified by V.V. Sacharov in 1932, the early work of Rapoport 
led to the identification of a number of mutagenic agents: formaldehyde, urotropine, acrolein, ethylene oxide, ethyleneimine, diethylsul-
phate, diazomethane and N-nitrosomethylurethane.  As with Auerbach, Rapoport used Müller’s ClB method to assess mutagenic effects in 
Drosophila. The first article on these discoveries: “Carbonyl compounds and chemical mechanisms of mutations” was published in 1946 
and several other papers were published until 1948.
As an opponent to Lysenkoism and refusing to recognize his “error” Rapoport was excluded from the Communist Party and from 1949 to 
1957 he worked as a paleontologist and stratigrapher. In 1957 (Stalin died in 1953) Rapoport joined the Institute of Chemical Physics of the 
Academy of Sciences in Moscow where he resumed his work on chemical mutagenesis. 
Rapoport established the mutagenic properties of 55 chemical compounds including the nitrososureas, which he called “super muta-
gens” and still are largely used in plant chemical mutagenesis today. A centre for introduction of chemical mutagenesis in the biosynthetic 
(biotech) industry and agriculture was created in 1965. Headed up by Rapoport this centre had a tremendous impact in the utilization of 
the chemical mutagenesis in the Soviet Union, eastern European countries and other countries. Numerous mutant varieties were officially 
released in these countries and registered in the IAEA database; 383 chemically induced mutant varieties of major crop species were 
released in the former USSR alone by 1991. 
Later in his life Rapoport was awarded the most prestigious social and academic distinctions of the USSR.
References:
Beale, G. (1993) The discovery of mustard gas mutagenesis by Auerbach and Robson in 1941. Genetics. 134: 393–399. 
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Despite some controversy, alkylating agents are usu-
ally classified as SN1-type or SN2-type according to their 
kinetic properties.  Compounds for which the rate 
determining (slow) step in the alkylation reaction is a 
first-order kinetics formation of reactive intermediates 
independent of the substrate (in our case–DNA)  are 
designated SN1-type alkylating agents. Those com-
pounds, where the rate-determining step is a second-
order nucleophilic substitution reaction involving both 
the compound and the substrate (DNA) are designated 
SN2-type alkylating agents (Figure 12.3). 
The very reactive electrophilic species produced by the 
SN1-type alkylating agents are generated independently 
of the substrate and are relatively unselective towards 
the nucleophile they alkylate. Consequently, these com-
pounds alkylate nitrogen, oxygen and phosphate group 
sites in DNA. The SN2 compounds, where the substrate 
(DNA) participates directly in the generation of the reac-
tive species, react primarily with the most nucleophilic 
sites on DNA, i.e. the nitrogens N7 and N3 of guanine 
and N3 of adenine. (Figure 12.4, Table 12.1)
Although most of the commonly used alkylating 
agents in plant experimental mutagenesis produce simi-
lar spectra of alkylation lesions in DNA (Figure 12.4), dif-
ferences in alkylation mechanisms (SN1 vs SN2) give rise 
to differences in the proportions of lesions produced. 
Figure 12.2  Molecular structure of commonly used alkylating agents in plant mutagenesis, and carmustine and mechlorethamine, two 
bi-functional alkylating agents used in anti-neoplastic clinical practice.
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For example, 1-methyl-1-nitrosourea (MNU) and 1-ethyl-
1-nitrosourea (ENU) react via an SN1 mechanism and 
efficiently alkylate both nitrogens and oxygens in DNA. 
Methyl methanesulphonate (MMS), which reacts via an 
SN2 mechanism, predominantly alkylates the nitrogens 
at the DNA bases and produces little alkylation of the 
oxygens in DNA bases and in the sugar–phosphate 
backbone (Figure 12.4; Table 12.1).
Alkylating agents are commonly divided into two 
classes: mono-functional and bi-functional. The alkyl-
ating agents usually used in plant experimental muta-
genesis and mutation breeding are mono-functional. 
Bi-functional alkylating agents (Figure 12.2) such as the 
chloroethylating agents (e.g. 1,3-bis(2-chloroethyl)-1-ni-
trosourea–BCNU), the nitrogen mustards  or mitomycin 
C, are characterized by their ability to induce DNA 
strand cross-links and are utilized as anti-neoplastic 
compounds. This last class of alkylating agents has not 
been utilized in plant mutation breeding experiments.
2.2. Properties of the Alkylating Agents 
The physical and chemical properties of the alkylating 
agents and of innumerous other chemicals, as well as 
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Figure 12.3   The SN1 and SN2 mechanisms of alkylation.
Table 12.1: Alkylation products of major representative SN1 (MNU, ENU) and SN2 (MMS) compounds 
a
Alkylation products MNU ENU MMS
O2-alkylcytosine < 1 < 1 < 1
N3-alkylcytosine < 1 < 1 < 1
N3-alkylguanine < 1 < 1 < 1
O6-alkylguanine 6 ~ 7 0.2
N7-alkylguanine 65 ~ 13 83
O2-alkylthymine < 1 ~ 5 < 0.1
N3-alkylthymine < 1 ~ 1 < 1
O4-alkylthymine < 1 ~ 5 < 0.1
N1-alkyladenine 2 ~ 1 1
N3-alkyladenine 7 ~ 6 11
N7-alkyladenine 2 ~ 1 2
Phosphotriesters 20 ~ 65 1
a Data kindly provided by Prof. A. E. Pegg, Dep. of Cellular and Molecular Physiology, Milton s. Hershey Medical center, Pennsylvania 
State University College of Medicine, Hershey Pennsylvania 17033, USA
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information regarding their biological activity, chemical 
structure, and other properties, can be retrieved from 
the Pubchem database (http://pubchem.ncbi.nlm.
nih.gov). The Substance Identity and the Compound 
Identity codes for some alkylating agents are given in 
Table 12.2. Both codes can be used interchangeably after 
accessing the database provided that the respective links 
“Substance” or “Compound” are previously selected. 
Many other databases are available, inter-linked and 
inter-active. For example, the Toxicology Data Network 
(http://toxnet. nlm.nih.gov) links over a dozen different 
databases (including Pubchem). Broad and regularly 
updated and peer-reviewed information regarding 
multiple aspects of the compounds, from physical 
and chemical properties to biological activity and risk, 
handling, clean-up, disposal, etc., can be found in 
these databases. Box 12.2 shows a partial example of 
the information that can be retrieved from Toxnet – in 
this case showing information regarding the inactivation 
and disposal of solid waste and mutagenic solutions 
after 1-methyl-1-nitrosourea treatments. Some general 
rules for inactivation of alkylating compounds are pro-
vided simultaneously.
2.3. Major Alkylation Adducts and their Repair
Eleven sites in the four bases and the phosphodiester 
groups  constitute the 12 most common targets for the 
alkylating agents in DNA (Figure 12.4).  Nevertheless, 
additional minor sites can be identified, such as the 
exocyclic 2-amino group of guanine in which alkylation 
by the bi-functional agent mitomycin C was recently 
determined.  
N7alkylguanine – the most nucleophylic site in DNA, 
the N7 position of the guanine is the primary alkylated 
site in DNA. Although this represents the bulk of the 
DNA alkylation by most alkylating compounds, this 
altered base is, apparently, non-mutagenic. 
O6alkylguanine – a major characteristic product of the 
SN1-type alkylating agents O
6-alkylguanine is strongly 
mutagenic since it mispairs with thymine and gives 
rise to G:C – A:T transitions. The repair of this lesion 
is particularly crucial in humans, given that besides 
the mutagenic implications there is a very well estab-
lished strong correlation between the formation of this 
adduct and carcinogenesis. This DNA lesion is repaired 
in many prokaryotes and eukaryotes through a direct 
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Figure 12.4  Most frequently alkylated sites in DNA.
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reversal and suicidal mechanism by O6alkylguanine-
DNA-alkyltransferases, which transfer the alkyl group 
from DNA to a cystein of the active site, which results in 
the inactivation of the repair protein. 
The recent sequencing of the Arabidopsis genome 
revealed the absence of O6alkylguanine alkyltransferase 
gene homologues in this plant species. The absence of 
similar gene homologues in other plants may explain the 
negative experimental results obtained regarding this 
repair activity in some plants (and in Chlamydomonas). 
Additional and alternative mechanisms for the repair of 
this adduct have been recently identified (Figure 12.5). 
One of the mechanisms implicates the product of alkyl-
transferase like (ATL) genes in the repair of this lesion via 
nucleotide excision repair (NER). 
O4alkylthymine – usually a minor lesion, even for 
SN1 compounds, this altered base can mispair with 
guanine and lead to A:T–G:C transitions. Directly 
repaired by Ogt and Ada (two different O6-alkylguanine-
DNA-alkyltansferases) gene products in bacteria this 
lesion is very inefficiently repaired by the mammalian 
O6-alkylguanine-DNA-alkyltansferase protein (known 
as MGMT or AGT). It should be noted that 1-ethyl-
1-nitrosourea tends to induce more A:T–G:C transitions 
than the related compound 1-methyl-1-nitrosourea 
(Table 12.3), which is in accordance to the  higher 
alkylation rate of the O4 position of the thymine by the 
ethylating (vs. methylating) compounds (Table 12.1). 
N3alkyladenine – although induced by all alkylating 
agents this altered base is a major product of the SN2-
Table 12.2: Commonly used alkylating agents in plant mutagenesis and mutation breeding
Compound IUPAC name Acronym(s) Substancea identity (SID) Compoundb identity (CID)
1-methyl-1-nitrosourea NMU (MNU) 24897498 12699
1-ethyl-1-nitrosourea NEU (ENU) 24897681 12967
methyl methanesulphonate MMS 49815676 4156
ethyl methanesulphonate EMS 24896575 6113
dimethyl sulphate DMS 24893559 6497
diethyl sulphate DES 24859256 6163
1-methyl-2-nitro-1-nitrosoguanidine MNNG 49855726 9562060
1-ethyl-2-nitro-1-nitrosoguanidine ENNG 77654587 5359974
N,N-dimethylnitrous amide NDMA 24897656 6124
N,N-diethylnitrous amide NDEA 49855498 5921
a , b Use the SID or the CID code to find the mutagen in the Pubchem database, respectively under Substance or Compound, to retrieve 
information regarding chemical structure, properties, safety, and other information about the compounds.
Table 12.3: Mutation spectrum of the alkylating agents at the molecular level
Compound G:C – A:T (%) A:T – G:C (%) Transvertions (%) Other
MNU ~100 - - -
ENU 72 21 6 -
MMS 20 14 66 -
EMS 93 1 2 4
NDMA 90 < 5 - -
NDEA 60 21 9 10
MNNG 98 < 2 - -
ENNG 95 5 - -
DMS 74 3 20 3
142
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?
Figure 12.5  During DNA replication, thymine can be incorporated opposite O6-alkylG if this lesion is not repaired by the direct reversal 
mechanism via MGMT/AGT proteins. The O6-methylG:T mispair can be recognized by the mismatch repair (MMR) machinery, but the 
excised thymine is replaced again by thymine resulting in a ”futile” repair cycle which can lead, on a further round of DNA replication, to the 
induction of DNA DSBs. DSBs can be repaired by the HR or non-homologous end joining (NHEJ) pathways, but can also result in clastogeny, 
SCE formation and/or apoptosis. Nucleotide excision repair (NER), a possible mechanism for repair of larger adducts, can, in some organ-
isms, be recruited by alkyltransferase like (ATL) proteins to repair O6-methylG, possibly even before S1. S1 and S2:  first and second rounds of 
DNA replication after alkylation. Adapted from: Margison et al. (2002) Mutagenesis. 17: 483–487. 
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type compounds. This lesion and that of N3alkylguanine 
is repaired by the base excision repair (BER) mecha-
nism, which initiates the removal of the altered base 
by a glycosylase activity that generates an abasic site in 
the double helix. Methyl methanesulphonate (MMS), 
an inducer of these two lesions, has been used for the 
study of this DNA repair mechanism in the various bio-
logical systems. 
N1alkyladenine and N3alkylcytosine – these two minor 
cytotoxic lesions are also preferentially induced by SN2 
agents, which could explain the increased frequency of 
transversion mutations after MMS treatments. These two 
adducts were recently shown to be repaired by a direct 
reversal mechanism involving oxidative DNA demeth-
ylases (Alk-B in E. coli). In contrast to the O6alkylguanine-
DNA-alkyltransferase, homologues to the Alk-B gene 
have been already identified in Arabidopsis thaliana.
Alkylphosphotriesters – the alkylation of phosphodies-
ters in DNA results in alkylphosphotriesters, which in E. 
coli are repaired by the Ada-protein while in mammals 
they are assumed to be very poorly or even not repaired 
by the alkyltransferase protein (MGMT/AGT). It is note-
worthy that for the SN1 compounds MNU and ENU the 
alkylphosphotriesters account for  approximately 20% 
and 70% of all alkylation adducts, respectively, and 
that there is an almost negligible amount of this lesion 
induced by the SN2 compound MMS (Table 12.1).
The relative frequency of induction of a specific 
pre-mutagenic lesion in DNA depends mostly on the 
properties of the mutagen, e.g. SN1 vs. SN2 compounds 
or methylating vs. ethylating agents. The ultimate muta-
genic effect of a chemical agent, however, depends 
on the lesions initially induced in the DNA, the lesions 
that remain unrepaired and the mutagenic effect of the 
repair mechanisms themselves. 
When not repaired, the pre-mutagenic adducts tend 
to give rise to fixed mutations. The alkylated O6guanine 
tends to produce G:C to A:T  transitions. The alkylated 
N3adenine gives rise to A:T to T:A transversions, while 
the non-repaired alkylated N3cytosine can result in 
C:G to T:A transitions and C:G to A:T and  C:G to G:C 
transversions.
The elucidation of the fate of the alkylation products 
in plants constitutes one of the main challenges for 
plant experimental mutagenesis. The clarification of 
these processes will allow a better understanding of the 
mutational processes that determine success in plant 
mutation breeding.
3. Mutagenesis of Alkylating Agents 
 in Plants
3.1. Mutagenicity 
3.1.1. DNA Breakage and Clastogenicity
Despite the relative absence of experimental data on 
the fate of the formed DNA adducts, the mutagenicity 
and the clastogenicity of alkylating agents in plants has 
been documented for more than 40 years. The study 
of the clastogenic effects of alkylating agents and other 
chemical compounds in plants had, and still has, two 
main goals: 1) the assessment of several aspects of plant 
cell biology related to the plant response to chemical 
compounds, and 2) the study of the biological activity 
of chemical compounds using plants as biological assay 
in order to draw conclusions concerning the risk they 
represent to the environment and human health (e.g. 
risk of carcinogenicity). The sensitivity and reliability 
of the plant bioassays have been recognized by vari-
ous prestigious international organizations such as the 
World Health Organization, which recommend their 
use for mutation screening and for detection of geno-
toxins in the environment.
Among the multitude of plant species used for such 
purposes, Crepis capillaris, Lycopersicon esculentum, 
Pisum sativum and Zea mays were the subjects of com-
prehensive and informative revisions (e.g. Grant and 
Owens, 2001). From these and other sources it is clear 
that all major alkylating agents (EMS, ENU, MNU, DES, 
etc.) show a positive clastogenic effect in all tested plant 
species. Effects can be seen at the cytological level and 
recorded as bridges and fragments in anaphase and 
telophase cells, as translocations, deletions, insertions, 
inversions, ring chromosomes, etc. in metaphase C 
cells, and as micro-nuclei in interphase and mitotic 
cells. 
Regarding the clastogeny induced by alkylating 
agents in plants, it was found that prior treatment of 
root meristems with low doses of these compounds 
(or with environmental stress factors as heat-shock or 
heavy metal salts) induced a protective (reducing) effect 
against subsequent treatments with higher doses of 
alkylating agents. By analogy with the bacterial “adap-
tive response” to alkylating agents, this phenomenon 
was named “clastogenic adaptation”.
The molecular basis of “clastogenic adaptation” in 
plants was studied in correlation with the formation 
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and removal of O6alkylguanine (Baranczewski et al., 
1997). Nevertheless, the apparent absence of the repair 
protein O6alkylguanine-DNA-alkyltransferases in plants 
requires all former experimental data on “clastogenic 
adaptation” to be re-thought in the light of this new 
information. New explanations, including the role of 
other O6alkylguanine repair mechanisms, are required.
DNA breakage is assumed to be the phenomenon 
that underlies the formation of chromosome aberra-
tions and chromosome rearrangements. During the 
last two decades the assessment of genotoxic and 
clastogenic effects of chemical compounds in plants 
has been complemented with the direct assessment 
of DNA breakage, primarily using the single cell gel 
electrophoresis (SCGE) technique also known as the 
“Comet assay” (see Chapter 11).
While simultaneously evaluating DNA damage and 
somatic mutations in leaves of Nicotiana tabacum, 
Gichner et al. (1999) ranked the mutagenic potency of 
the four main alkylating agents as: MNU > ENU ≈ MMS 
> EMS. With respect to DNA damaging activity the rank 
order was slightly different: MNU > MMS > ENU > EMS. 
The reliability of the Comet assay in assessing DNA 
damage in different plant species is well established 
and a clear correlation between the extent of DNA 
damage and the concentration of the mutagen used 
has been observed in a wide range of species, including 
sugar beet, alfalfa, tobacco, lentil, maize, potato, durum 
wheat and bread wheat (Gichner et al., 2003).  A corre-
lation between “clastogenic adaptation” expressed as a 
reduction of chromatid type aberrations, micro-nuclei 
and aneuploid cells, and the “clastogenic adaptation” 
expressed as a reduction of damaged DNA assessed by 
the “comet assay”, was observed after the treatment with 
non-toxic doses of cadmium chloride prior to the chal-
lenge treatment with a high dose (5 mM, 2 h) of MNU.
3.1.2. Nature of Induced Mutations
Chemical mutagens in the early studies were termed 
“radiomimetic” due to the similarity of their effects com-
pared with the radiation effects on biological systems. 
To the best of our knowledge, an extensive compara-
tive analysis of the total spectra of mutations induced 
by radiation vs. chemical agents has never been carried 
out in plants. Nevertheless, in spite of differences in 
genome organization or cell cycle phase-dependent 
differences in chromatin packing that could determine 
differences in the accessibility of chemical compounds 
to DNA, the ultimate DNA lesions induced by chemical 
mutagens: transitions, transversions, deletions, inser-
tions, inversions, DNA single- and double-strand breaks 
and DNA recombination are similar, though in different 
proportion, to those induced by radiation. The spec-
trum of mutations induced by chemical and physical 
mutagens, in particular the so called “visible”, ”macro” 
or phenotypic mutations (chlorophyll, morphological, 
physiological) is expected to be similar.
Some mutations such as those conferring increased 
(plastome encoded) herbicide or antibiotic resistance 
seem to be more frequent in chemical (alkylating com-
pounds) mutagenesis. However, the identification of 
these mutations may be simply the result of the applied 
selection procedures. 
A major difference between chemical and physical 
mutagenesis is the possibility of achieving higher muta-
tions rates with minimal effects on survival and fertility 
of M1 plants by chemical mutagens, a situation that does 
not seem possible with acute treatments of physical 
mutagens. 
3.2. Plant Materials and Methods of Treatment
3.2.1. Types of Plant Material
Chemical mutagenesis can be performed with all types 
of plant materials, from whole plants (usually seedlings) 
to in vitro cultured cells. Nevertheless, the most com-
monly used plant material is seed. Multiple forms of plant 
propagules such as bulbs, tubers, corms and rhizomes 
and explants used for plant vegetative propagation such 
as vegetative cuttings, scions, or in vitro cultured tissues as 
leaf and stem explants, anthers, calli, cell cultures, micro-
spores, ovules, protoplasts, etc., are also used. Gametes, 
usually inside the inflorescences, are also targeted to 
mutagenic treatments (immersion of spikes, tassels, etc. 
into mutagenic solutions, see Chapter 14). 
3.2.2. Types of Treatment
Mutagenic treatments are usually performed on plant 
tissues and result in multiple different mutations 
induced in a large number of cells, most of which nor-
mally do not develop into new plants. In vitro culture 
methods provide an exception in the sense that, for 
species where regeneration protocols are established, 
any mutated cell has the potential to regenerate into 
a new plant and thereby transmit its mutations to the 
next, sexual or vegetative, generation. 
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Box 12.2: Precautions for (and inactivation of) alkylating, arylating and acylating compounds 
Precautions for “Carcinogens”: Carcinogens that are alkylating, arylating or acylating agents per se can be destroyed by reaction with 
appropriate nucleophiles, such as water, hydroxyl ions, ammonia, thiols and thiosulphate. The reactivity of various alkylating agents varies 
greatly ... and is influenced by solubility of the agent in the reaction medium. To facilitate the complete reaction, it is suggested that the 
agents be dissolved in ethanol or similar solvents. ... No method should be applied ... until it has been thoroughly tested for its effectiveness 
and safety on material to be inactivated. For example, in case of destruction of alkylating agents, it is possible to detect residual compounds 
by reaction with 4(4-nitrobenzyl)-pyridine.
1. Oxidation by potassium permanganate in sulphuric acid (KMnO4 in H2SO4). The products of the reaction have not been determined. 
Degradation efficiency was >99.5%. 
2. Reaction with sulphamic acid in hydrochloric acid solution (HCl). The strong hydrochloric acid causes displacement of the nitroso 
group. The nitrosyl chloride formed reacts with the sulphamic acid to form nitrogen and H2SO4. This reaction prevents any reformation 
of the nitrosamide. The products of the reaction are the corresponding amides produced by simple removal of the nitroso group. 
Degradation efficiency was >99.5%. 
3. Reaction with iron filings in HCl solution. The strong HCl causes displacement of the nitroso group. The nitrosyl chloride formed 
is reduced by the iron filings in the acid to ammonia. This reaction prevents any reformation of the nitrosamide. The products of 
the reaction are the corresponding amides produced by simple removal of the nitroso group except for N-methyl-N’-nitro-N-
nitrosoguanidine and N-ethyl-N’-nitro-N-nitrosoguanidine, where reductive removal of the nitro group causes the major products to 
be methylguanidine and ethylguanidine, respectively. Degradation efficiency was >99%. 
4. Reaction with sodium bicarbonate solution (NaHCO3). This weak base causes a slow, base-mediated decomposition. The rate of 
reaction is sufficiently slow so that any diazoalkanes that are formed react with the solvent before escaping from the solution. The 
products of the reaction have not been definitely identified. Degradation efficiency was >99.99% for N-methyl-N-nitrosourea, N-ethyl-
N-nitrosourea, N-methyl-N-nitrosourethane and N-ethyl-N-nitrosourethane. The method is not suitable for N-methyl-N’-nitro-N-
nitrosoguanidine, N-ethyl-N’-nitro-N-nitrosoguanidine, or N-methyl-N-nitroso-p-toluenesulphonamide. 
5. Reaction with NaHCO3 solution, then nickel-aluminum (Ni-Al) alloy and sodium carbonate (Na2CO3) solution, then potassium 
hydroxide (KOH) solution. The slow increase in pH of the solution produced by sequential addition of the bases causes a slow 
degradation of the nitrosamide. The degradation rate is sufficiently slow so that any diazoalkanes that are formed have time to react 
with the solvent before escaping from the solution. Degradation efficiency is >99.9%. 
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Table 12.4: Half-life of some alkylating agents in water solution at different temperatures and pH 
[Unit: T0.5(h)]
Mutagens Temp (°C) pH6 pH7 pH8
MNU 20 (22) 24 (2.3)
ENU 20(22) 31 (2.4)
EMS 20 (25) 93.2 (7.8)
MNNG 22 2.5
ENNG 22 7.0
One of the practical issues that concerns researchers and 
breeders is the optimization of the mutagenic treatments 
of the generative cells that will transmit mutations to the 
next (M2) generation via sexual reproduction while lower-
ing the injury of other tissues which will decrease plant 
survival or result in higher sterility in the M1 generation.  
During chemical mutagenic treatments, time (usu-
ally a few hours) is needed for the mutagen to reach 
the apical and/or axillary meristems in seed embryos, 
propagules, buds, etc., which are protected, respec-
tively, by the seed testa and cotyledons and/or by 
primordial and adult leaves. In addition, during the 
mutagenic treatments the chemical mutagens undergo 
spontaneous degradation (Table 12.4) and part of the 
reactive chemical species will be lost in reactions (e.g. 
alkylation reactions) with the contents of tissues and 
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Table 12.5: Examples of mutagenic treatments with the most commonly used alkylating agents
Alkylating  agent Plant species Plant material Concentration
(mM)
Exposure References
MNU  
(MW 103.08)
Begonia Leaf explants (in 
vitro)
0.2–10 1 h Bouman and De Klerk (2001) Theor 
Appl Genet, 102: 111–117
Lathyrus sativus Pre-soaked seeds 
(12 h)
0.5–1.4 3 h Rybinski (2003) Lathyrus Lathyrism 
Newsletter, 3: 27–31
Lens culinaris Seeds 0.49–3.88 6 h Sharma and Sharma (1986) Theor Appl 
Genet, 71: 820–825
Nicotiana glauca Pre-soaked seeds 
(16 h)
1 2 h Marcotrigiano and Hackett (2000) 
Annals of Botany 86: 293–298
Oryza sativa Panicles 1 45 min Suzuki et al. (2008) Mol Genet 
Genomics, 279: 213–223
Pisum sativum Seedlings 1 1-4 h Pereira and Leitão (2010) Euphytica 
171: 345–354
ENU  
(MW 117.11)
Brassica oleracea
var. botrytis Pieces of curd (in 
vitro)
0.3 Days Deane et al. (1995) Euphytica, 85: 
329–334
Nicotiana 
plumbaginilfolia
Protoplasts 0.1 Days Rey et al.  (1990) Plant Cell Reports, 9 
(5): 241–244
Phaseolus vulgaris Seeds 1.5–6.2 8 h Svetleva (2004) J. Central European 
Agriculture, 5 (2): 85–90
Pisum sativum Seedlings 5 1–4 h Pereira and Leitão (2010) Euphytica 
171: 345–354
Zea mays Callus 1–30 4–8 h Moustafa et al. (1989) Plant Cell and 
Tissue and Organ Culture, 17: 121–132
EMS 
(MW: 124.16)
Glycine max Embryogenic 
cultures
1–30 4 h Hofmann et al. (2004) Biologia 
Plantarum, 48 (2): 173–177
Glycine max Seeds 18 24 h Wilcox et al. (2000) Crop Sci. 40: 
1601–1605
Helianthus annus Pre-soaked seeds 
(4h)
80 5–12h Nehnevajova et al.  (2007) International 
Journal of Phytoremediation, 9: 149–165
Oryza sativa Panicles 94.2 (injected) Lee et al. (2003) Genetics and 
Genomics, 22: 218–223
Phaseolus vulgaris Seeds 6.2–25 8 h Svetleva (2004) J. Central European 
Agriculture, 5 (2): 85–90
Trigonella 
foenum-graecum
Pre-soaked seeds 
(4h)
10–300 2–24 h Saikat et al. (2008) Euphytica, 160: 
249–258
cells other than the target meristematic cells, which will 
be reached some hours later by a depleted mutagenic 
solution.
To overcome this problem, the renewal – at least par-
tial – of the mutagenic solution during the treatments has 
been suggested, which implies the repeated manipula-
tion of the mutagen and the need for additional muta-
genic solution. Another option is to pre-soak seeds (or 
other type of plant material) in water or buffer for some 
hours prior to mutagenic treatment. This allows the 
mutagen to diffuse more rapidly to the tissues of inter-
est (meristems).  Depending on the species and the 
experimental design diverse times of pre-soaking, from 
shorter periods of 4–5 hours to longer periods of 12–16 
hours, may be used (Table 12.5). A third option is to pre-
germinate seeds and to treat seedlings (Table 12.5). This 
procedure facilitates the access of the mutagens to the 
apical and axillary meristems and reduces the time of 
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exposure to 1–2 hours. This has advantages in providing 
almost full survival and fertility among the M1 plants and 
very high mutation rates in the M2 generation. A range 
of other tissues can be pre-soaked or pre-germinated 
for use in vivo and in vitro mutagenesis (bulbs, corms, 
tubers, etc.).
In certain specific circumstances, other types of treat-
ment may be used in chemical mutagenesis, including 
dipping inflorescences such as spikes or tassels in muta-
genic solutions, or injection of mutagenic solutions in 
stems or culms, etc. There are also some reports of in 
vitro treatments, in which plant tissues are cultivated 
in the continuous presence of low concentrations of 
mutagenic agents (Table 12.5).
3.2.3. Concentration of Mutagens, pH and  
Exposure Time
It is advisable that the concentrations of the mutagens to 
be used is established and reported in molar units. Molar 
units refer to the number of molecules of the mutagen in 
the solution and facilitates the comparison of the biologi-
cal effects of different mutagenic agents on an equimolar 
basis. In many earlier works mutagen concentrations are 
reported as percentage units, (v/v) or (w/v).
Some general conclusions can be reached by com-
paring the most used alkylating agents EMS, ENU and 
MNU. In acute treatments, EMS is frequently used 
at ranges of 10–100s milli-molar concentrations (e.g. 
10–100 mM and over); ENU is generally used at con-
centrations an order of magnitude lower (e.g. about 
5–6 mM) while MNU is usually used at much lower 
concentrations (e.g. 0.2–1.0 mM).  The most important 
limiting factor regarding the mutagenic concentration is 
the toxicity of the compound, which rapidly increases 
with concentration and shows a clear negative effect on 
the survival and fertility of the M1 progeny.  
When used as a solid substance, the alkylating agents 
need first to be dissolved in appropriate solvents such 
as ethanol or DMSO and then added to buffers or 
water.  The pH of the buffers is usually neutral or slightly 
acid (pH 6–7), this helps to minimize degradation of the 
mutagens (Box 12.2). Commonly used buffers include 
the phosphate buffers, in particular the Sorensen’s 
phosphate buffer, at pH 6.8–7.0. Distilled water is 
slightly acidic and is also commonly used. 
Exposure time varies substantially depending on the 
type of plant material and concentration, but usually 
ranges from 1 to 6–12 hours.
3.3. Handling M1 and M2 Generations
As for physical mutagenic agents, the level of injuries 
induced by the alkylating agents in M1 plants can be 
assessed as germination and/or field emergence rates 
and parameters such as survival–percentage of plants 
that attain the adult phase; sterility–percentage of adult 
plants that do not produce progeny; plant morphoses, 
chlorophyll chimeras, plant height, number of inflores-
cences, number of fruits, fertile branches, fertile nodes, 
number of seeds, etc. (see Chapter 14). Several param-
eters can be conceptualized and analysed in different 
ways, for example: sterility can be assessed establishing 
multiple levels of expression from less sterile plants to 
totally sterile plants.
Much work has been dedicated to correlating injuries 
to the M1 plants with mutagenic rates in the M2 prog-
eny. This has been done in order to establish predictive 
rules in generating the required mutant variation in the 
subsequent M2 generation. Lethal dose thresholds have 
also been investigated. It became commonly accepted 
that doses inducing 25 to 50% lethality (LD25–LD50) 
among the M1 plants will result in the highest mutations 
rates. Most of these parameters were developed from 
treatments of dry seeds which required relatively long 
treatment times, and this resulted in relatively high 
lethal injury to embryonic tissues. However, the use 
of protocols that minimize the injury to M1 plants (e.g. 
pre-soaking seeds or carrying out short mutagenic treat-
ments on germinated tissues) allow very high mutation 
rates in the M2 generation to be reached while signifi-
cantly reducing the lethality among the M1 plants.
The normal, general mutation breeding methods 
apply to chemical mutagenesis. The pedigree method 
where M1 plants are individually harvested and individ-
ually sown as M2 families and the bulk method where all 
M1 plants are bulk harvested and the bulked M2 progeny 
is sown are commonly used. These two main breeding 
methods contrast in the way mutation rates are calcu-
lated: 1) Pedigree method – as percentage of M2 families 
with mutations and 2) bulk method – as percentage of 
mutated M2 plants. The first method however, permits a 
better correlation to be established between the M1 and 
M2 generations, as well as providing a better compari-
son between biological effects of different mutagens.  
In a broad sense, and often in practise, an M2 family 
is taken to be the progeny of an M1 plant. However, this 
concept can be further constrained and an M2 family 
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can be formed from the progeny of a plant branch, 
individual spike, etc. 
4. Other Chemical Mutagens
Paraphrasing the title of an article published by Ferguson 
and Denny (1995) it can be said that multiple groups of 
chemical compounds can be classed as an “underuti-
lized resource” in plant chemical mutagenesis. Some of 
the promising compounds are discussed below.
4.1. Nitrous Acid and Nitric Oxide
4.1.1. Properties
The mutagenic effect of nitrous acid (HNO2) in virus, 
bacteria, fungi and yeast was documented more than 
five decades ago. More recently nitric oxide (NO) was 
found to exert, through similar pathways, similar effects 
on biological systems. Both compounds induce two 
major types of mutations: transitions and DNA inter-
strand cross-links.  
Although hydrolytic deamination of the bases in DNA 
occurs spontaneously, nitrous acid and nitric oxide 
increase deamination rate, in particular of guanine. 
Both compounds induce nitrosamine deamination of 
adenine to hypoxantine (Hx), of cytosine to uracil and 
of guanine to xanthine (Xan) and oxanine (Oxa) at a 
molar ratio of 3:1 (Figure 12.6).
Hypoxantine pairs with cytosine lead to AT→GC tran-
sitions, while uracil pairs with adenine induce CG→TA 
transitions. Xanthine and oxanine can pair with cytosine 
or with thymine, in the latter case leading to GC→AT 
transitions.
Inter-strand cross-links are formed preferentially in 
5’CG sequences where the two guanines on opposite 
strands remain covalently linked through a shared exo-
cyclic amino group (Figure 12.7).
Uracil and hypoxantine are repaired by the BER 
pathways, whereas an alternative repair pathway is 
deployed for hypoxanthine involving endonuclease V 
(recently identified in E. coli). Oxanthine seems to be 
repaired less efficiently than xanthine, via BER or NER 
pathways. The fate of the nitrous acid and nitric oxide-
induced DNA inter-strand cross-links as well as the con-
sequences on the ability of oxanine to form cross-link 
adducts with aminoacids, polyamines and proteins are 
currently very poorly understood. 
In plants, nitric oxide is assumed to play an important 
role in plant growth and development and to be a ubiq-
uitous signal involved in the induction of cell death and 
of defence genes, and in the interaction with reactive 
oxygen species during defence against pathogens or in 
response to the plant hormone ABA. Bearing in mind 
that nitric oxide over-production in chronically inflamed 
tissues has been implicated in carcinogenesis and that 
NO releasing compounds are potent growth inhibitors 
of  cancer cell lines and prevent colon and pancreatic 
cancer in animal models, the study of nitrous acid and 
nitric oxide effects in biological systems is expected to 
expand. 
4.1.2. Nitrous Acid and Nitric Oxide in Plant  
Mutagenesis 
Although, nitrous acid mutagenesis is used for genetic 
improvement of virus, fungi and bacteria for multiple 
biotechnological purposes, its exploitation in plant 
genetic improvement has been lacking.  Since nitrous 
acid is quite unstable, the mutagenic treatments with 
nitrous acid need to be quick, e.g. not longer than a 
few minutes, which makes the treatment of dry seeds 
ineffective. Young seedlings and especially in vitro cul-
tured plant cells, tissues and other vegetative explants 
offer more potential as targets for nitrous acid muta-
genesis. The low pH at which nitrous acid needs to be 
maintained is an additional stress factor that needs to 
be considered in any nitrous acid treatment of plant 
materials.
Protocols for nitrous acid (HNO2) mutagenic treat-
ments: nitrous acid needs to be prepared fresh at low 
temperatures (0°C) before each treatment. Usually 
potassium or sodium nitrites are solubilized in acetate 
buffer at pH 4.0–5.5. Alternatively, identical volumes of 
solutions with equi-molar concentrations of sulphuric 
acid and barium nitrite are mixed and the barium sul-
phate removed by centrifugation. This last solution has 
a very low pH (1.5). Mutagenic treatments are usually 
performed with 0.02 to 0.1 M solutions.
4.2. Base Analogues and Related Compounds 
4.2.1. Types and Effects
Under specific conditions some base analogues (Figure 
12.8), and their ribosides and deoxyribosides, can be 
more mutagenic to specific organisms than the alkylat-
ing agents. The analogue of thymine 5-bromo-uracil 
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(BU) – and its deoxyriboside 5-bromo-2’-deoxyuridine 
(BUdR) – can incorporate into DNA and induce GC→AT 
and AT→GC transitions, and AT→TA and CG→AT trans-
versions, as well as small indels that cause frameshift 
mutations, both in vivo and in vitro. 
The ability of BUdR to incorporate into newly syn-
thesized DNA strands is exploited in sister chromatid 
exchange analyses, and the anti-proliferative and 
radiosensitizing properties of this compound are being 
tested for anti-neoplastic treatments.
Other base analogues such as 2-aminopurine (2AP), 
2,6-diaminopurine (2,6DAP), 6-N-hydroxylaminopurine 
(HAP) and 2-amino-6N-hydroxylaminopurine (AHAP) 
can function as analogues of adenine or guanine and 
can be incorporated into DNA where they induce 
high rates of C:G to T:A and T:A to C:G transitions and 
frameshift mutations. 2AP and 2,6DAP are very effective 
mutagens to phages and bacteria but weak mutagens to 
eukaryotic cells and weak  carcinogens in mammalian 
systems. In contrast, HAP and AHAP are strongly muta-
genic to eukaryotic cells and relatively carcinogenic. 
The clastogenic effect of base analogues in plants, 
including related compounds such as the alkylated 
oxypurines: 8-ethoxycaffeine and 1,3,7,9-tetramethylu-
ric acid, was established over three decades ago almost 
simultaneously with the determination of the ability of 
some of these compounds to induce visible mutations 
in plants. Nevertheless, base analogues have not been 
tested intensively for the induction of mutants of inter-
est in plants, and in this regard, the release of the malt-
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ing barley commercial variety “Fuji Nijo II” induced by 
BUdR + gamma rays treatment in Japan is exceptional.
 Maleic hydrazide (1,2-dihydro-3,6-pyridazinedione, 
MH) is a structural isomer of uracil with plant growth 
regulator properties and is commonly used as a herbi-
cide and sprout inhibitor. The genotoxic effects of this 
base analogue, particularly in plants, are rather intrigu-
ing and deserve further enlightenment.  MH shows low 
mutagenic activity in bacteria, fungi and animal cells 
with seemingly no carcinogenic effects. However, this 
compound exhibits high mutagenic, clastogenic and 
recombinational activity in plants, frequently stron-
ger than that of the most powerful alkylating agents 
(Gichner, 2003). In an experiment carried out simulta-
neously in two different laboratories the results of the 
comparative assessment of the genotoxicity of MH 
versus methyl methanesulphonate (MMS) in onion 
(Allium cepa) confirmed the much stronger clastogenic 
effect of MH: 24.0 and 46.4% cells with chromosome 
aberrations for concentrations of 5 mg/l and 10 mg/l, 
respectively, versus 19.1% aberrant cells for 10mg/l MMS 
(Rank et al., 2002).
MH effects revealed by comet assay were contrary 
to the expected, since no DNA damage was observed 
(Gichner, 2003). However, Juchimiuk et al. (2006) also 
used the comet assay and registered extensive DNA 
damage both in N. tabacum and human leucocytes when 
MH treatments were performed on previously isolated 
cell nuclei. The comparison of the contradictory results 
of these experiments raises the question of the role of 
in vivo DNA repair mechanisms in the mutagenic effect 
of MH. Intriguing results were also observed when 
MH was used in combined mutagenic treatments. As 
expected, a synergistic effect was observed when MH 
was combined with X-rays in inducting somatic muta-
tions in Trandescantia stamen hairs; but, conversely, an 
antagonistic mutagenic effect was registered when MH 
was combined with EMS.
4.2.2. Base Analogues and Plant Mutation  
Breeding
Apart from a very few exceptions, and despite the well 
documented genotoxic effects of MH in plants, reports 
on the use of this compound in plant mutation breeding 
Figure 12.8  Molecular structures of several base analogues.
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are lacking. The relative low toxicity and carcinogenicity 
of most of the base analogues, which are relatively inert 
and non-volatile compounds, are properties expected 
to encourage the utilization of base analogues in plant 
mutation breeding.  MH and other base analogues have 
been used as water or buffer (e.g. Tris HCl) solutions at 
5 to 10 mg/l. 
4.3. Antibiotics
4.3.1. Types and Effects
Antibiotics are defined functionally on the basis of 
their anti-microbial activity. This group of compounds 
includes a multitude of natural and synthetically synthe-
sized substances which, according to their molecular 
structure, fall into very different classes of compounds. 
Some antibiotics (Figure 12.9), such as streptozotocin, 
mitomycin C or azaserine, can also be included in the 
group of alkylating compounds. 
Streptozotocin (STZ) is a naturally synthesized broad 
spectrum antibiotic and  a potent mutagen and carcino-
gen used as a diabetogenic and anti-neoplastic agent. 
DNA-specific sequence analyses showed that over 
98% of the STZ-induced mutations were G:C to A:T 
transitions with a few A:T to G:C transitions. However 
STZ also produces DNA strand breaks, alkali-labile 
sites, unscheduled DNA synthesis, DNA adducts, 
chromosomal aberrations, micro-nuclei, sister chro-
matid exchanges and cell death. Although the ability 
of streptozotocin to induce visible mutations in plants, 
in particular chlorophyll mutations, was reported four 
decades ago this mutagen has not been taken up in 
plant breeding experiments.
Mitomycin C (MMC) is an antineoplastic antibiotic 
isolated from Streptomyces caespitosus that inhibits 
DNA, RNA and protein synthesis and induces apoptosis 
in mammalian cells, and intra-chromosomal recombi-
nation in plant somatic cells. MMC is a bi-functional 
alkylating agent that reacts with guanine residues 
to form DNA inter-strand cross-links at the 5-CG-3′ 
sequences and six types of guanine adducts, four of 
them arising from the direct alkylation of DNA by MMC 
and two other resulting from the previous formation of 
2,7-diaminomitosene (2,7-DAM), which then alkylates 
DNA (Paloma et al., 2001). 
Azaserine is a naturally occurring serine deriva-
tive with antineoplastic properties that functions as a 
purine antagonist and a glutamine amidotransferase 
inhibitor. Azaserine spontaneously decomposes to 
diazoacetate which carboxymethylates DNA, forming 
O6CmG, N7CmG and N3CmA as major products and 
O6meG and N7 and N3 methylpurines as minor products. 
The fluoroquinolone ciprofloxacin is a bacterial 
gyrase inhibitor that causes DNA DSBs and induces a 
wide pattern of mutations including different kinds of 
base pair substitutions and 3 or 6 base pair insertions/
deletions that result in frameshift mutations in bacte-
ria. At high concentrations ciprofloxacin inhibits the 
eukaryotic topoisomerase-II and induces genotoxic 
effects in mammalian cells in in vitro studies, whereas 
no genotoxic or carcinogenic effects were observed 
when used in in vivo tests with rodents. 
Some antibiotics are radiomimetic and induce 
predominantly SSBs and DSBs in DNA. A major rep-
resentative group of these antibiotics are the bleomy-
cins, a group of natural glycopeptides produced by 
Streptomyces verticillus. It has potent antitumor activity, 
which is commonly assigned to its strong induction of 
DNA breakage (Ferguson and Denny, 1995).
Many other antibiotics, such as fumagillin, amoxicillin 
and amoxicillin-related antibiotics, such as ampicillin, 
are also mutagenic to bacteria and mammalian cells, 
while others such as actinomycin D are potent apop-
totic agents.  
4.3.2. Antibiotic Mutagenicity Assays in Plants
The assessment of genotoxic effects of some antibiot-
ics, in particular the study of the induced DNA lesions 
and respective repair pathways, has been carried out 
in plants, though at a much lower scale compared with 
the number of similar studies performed in bacteria and 
mammals. 
The clastogenic properties of bleomycin have been 
determined in faba beans (Vicia faba), barley (Hordeum 
vulgare) and Crepis capillaris root cells. The formation and 
repair of bleomycin-induced DNA breaks in faba beans 
was assessed by neutral elution and by the comet assay. 
The very fast repair of bleomycin-induced strand breaks 
was first documented in Arabidopsis and more recently 
confirmed in barley (Georgieva and Stoilov, 2008). 
Among the non-alkylating mutagenic compounds 
antibiotics have been the most extensively used in plant 
mutation breeding, with particular success in the induc-
tion of male sterile mutants in a number of plant species. 
Twenty-two cytoplasmic male sterile (CMS) and seven 
nuclear male sterile (NMS) mutants were selected in 
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4.4. Intercalating Agents and Topoisomerase 
Inhibitors and Poisons
4.4.1. Intercalating Agents
Intercalating agents can reversibly intercalate with 
double-stranded DNA, but they do not covalently 
interact with it. Classical intercalating compounds such 
as acridinium salts, ethidium bromide and propidium 
iodide are fused-ring aromatic molecules with positive 
charges on an attached side chain and/or on the ring 
system itself. Other compounds, such as DAPI, contain 
unfused aromatic systems with terminal basic functions 
and are classified as non-classical intercalators.
Initially used as disinfectants and anti-parasitic com-
pounds, acridines and acridine derivatives constitute 
one of the biggest groups of the intercalating agents. 
These compounds have light absorbing properties and 
photo-enhanced cytotoxicity and mutagenicity and are 
exploited as dyes in biological and biochemical assays 
(e.g. acridine orange) and in clinics.
The most specific DNA lesion induced by the acridine 
compounds are frameshift mutations. The exploitation 
of these particular mutagenic properties allowed Francis 
Crick and co-authors to demonstrate the triplet nature 
of the genetic code using the acridine dye proflavine.
The genotoxic activity of acridines and related molecules 
differ from compound to compound. While simpler mol-
ecules, such as 9 amino-acridine and quinacrine, induce 
sunflower (Helianthus annus) after treatments of seeds 
with mitomycin C and streptomycin. Streptomycin 
proved to be more effective in the induction of male 
sterility mutations as 18 of the CMS mutants were 
induced by this antibiotic. Six of these CMS lines have 
been released by the USDA-ARS and the North Dakota 
AES (Jan and Vick, 2006). The efficiency of streptomycin 
to induce male sterile mutants was also proved in sugar 
beet, sorghum and pearl millet. In this last species male 
sterile mutants were also induced with mitomycin C. 
Streptomycin, penicillin, rifampicin, erythromycin and 
tetracycline were also tested for inducting male sterile 
mutants in Linum usitatissimum. 
Despite the very limited use of antibiotics in plant 
mutation breeding and the very few published studies 
on the genotoxicity of these compounds in plants, it is 
worth mentioning that among the new plant genomic 
tools stands the publicly available microarray data from 
the AtGenExpress initiative (http://www.arabidopsis.
org/info/expression/ATGenExpress.jsp). This includes 
the transcriptional response of 16-day old WT (Col) 
Arabidopsis thaliana seedlings to the genotoxic treat-
ment with (1.5µg/ml) bleomycin and (22 µg/ml) mito-
mycin C for different (up to 24 hours) exposure times. 
Treatment conditions with antibiotics can vary substan-
tially. Treatments with 50 to 200 µg/ml bleomycin, 5 to 
500 µg/ml mitomycin C, 5 to 5000 µg/ml streptomycin 
and 1–5 mg/ml azaserine have been used. 
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±1 frameshift mutations in bacteriophages and bacteria 
and are weak clastogens and mutagens to mammalian 
cells, other acridines such as quinacrine, amsacrine and 
anthracyclines are severe clastogens and carcinogens.
Acridines bearing additional fused aromatic rings 
(benzacridines) show little activity as frameshift muta-
gens, but following metabolic activation interact 
covalently with DNA inducing predominantly base pair 
substitution mutations (Ferguson and Denny, 2007). 
Nitroacridines have been shown to be mutagenic and 
clastogenic to mammalians. Some of these compounds, 
such as nitracrine and the 3-nitroacridine Entozon, 
exhibit a predominant induction of -2 frameshift muta-
tions.  Like the nitroacridines, the acridine mustards and 
aflatoxin B1 can induce frameshift mutations and base 
pair substitution. 
Acridine mustards, in which an alkylating mustard is 
attached to an intercalating acridine chromophore, 
can be 100-fold more cytotoxic than the free mustard. 
Some acridine mustards such as ICR-191 and C20 are 
known to form adducts to the N7 position of guanine, 
but analogues with longer linker chains, such as C5, can 
form adducts almost exclusively at the N1 position of 
adenine.
The recombinogenic and mutagenic activities of some 
mutagens, e.g. bleomycin, can be enhanced and syner-
gistic effects can be observed with pre-treatments with 
aminoacridines, nitroacridines or acridine mustards.   
4.4.2. Topoisomerase Poisons
Topoisomerases play critical roles in primary DNA 
processes such as replication and recombination as 
well as in chromosome segregation, condensation and 
decondensation.  While type I topoisomerases remove 
super-helical torsions in DNA generating temporary 
single breaks in one strand, type II topoisomerases 
alleviate DNA over-winds and resolve DNA knots and 
tangles by a similar mechanism but generate transient 
DSBs. In their function, topoisomerases establish the 
so called cleavage complexes, constituted by transient 
covalent attachment between the tyrosyl residues of 
their active site and the terminal DNA phosphates 
generated during the cleavage reaction. Compounds 
that stimulate the formation or increase the persistence 
of these topoisomerase-DNA cleavage complexes are 
referred to as “topoisomerase poisons”. Although there 
is some evidence for the involvement of topoisomerases 
in the induction of frameshift mutations, e.g. a functional 
T4 topoisomerase is required for 9-aminoacridine muta-
genesis in T4 bacteriophage, the strong clastogenicity of 
several intercalating agents has been ascribed to their 
topoisomerase II poisoning properties. 
Topoisomerase II poisons are strong cytoxic and/
or clastogenic compounds, since stabilized cleavage 
complexes can inhibit DNA replication and cause 
DSBs. Multiple anti-cancer drugs such as etoposide and 
doxorubicin and antibiotic compounds such as cipro-
floxacin and levofloxacin function as topoisomerase II 
poisons.
A second group of drugs that function by inhibiting 
the DNA binding and/or the catalytic cycle of topo- 
isomerases are referred to as topoisomerase catalytic 
inhibitors. They do not induce DSBs and exhibit lower 
cytoxicity. Examples of eukaryotic (human) catalytic 
inhibitors are aclarubicin and merbarone; the former 
prevents the binding of topoisomerase II to DNA and 
the latter inhibits the DNA strands cleavage activity of 
this enzyme (e.g. McClendon and Osheroff, 2007).  
Compounds that exhibit topoisomerase II poison-
ing activity can be found either among intercalating or 
non-intercalating agents. Genistein (a bioflavonoid), 
quinolones (e.g. CP-115,953), etoposide and teniposide 
are non-intercalating topoisomerase II poisons, while 
amsacrine, doxorubicin, mitoxantrone, proflavine and 
auramine are examples of intercalating topoisomerase 
II poisons (Figure 12.10). Quinones, which act as topoi-
somerase II poisons in the presence of cleavage com-
plexes and as topoisomerase catalytic inhibitors when 
previously incubated with the enzyme in the absence of 
DNA, and benzene are other examples of strong topo- 
isomerase poisons. Topoisomerase II catalytic inhibi-
tors can also be classed as intercalating agents, such 
as 9-aminoacrine, chloroquine, tacrine and ethidium 
bromide or non-intercalating as merbarone. 
Interestingly, topoisomerase II catalytical inhibitors 
can antagonize topo II poison activities. The attenu-
ation of the DNA cleavage-enhancing properties of 
teniposide, amsacrine and etoposide by merbarone, 
or the inhibition of the etoposide induced micro-nuclei 
formation by chloroquine, A-74932, 9-aminoacridine 
and ethidium bromide, are examples of such antago-
nistic interaction.
Topoisomerase II does not become a genotoxic 
enzyme uniquely by the direct poisoning effect of chem-
ical compounds. Poisoning effect on topoisomerase II 
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can be produced by double helix distortions caused by 
the presence of abasic sites generated by spontaneous 
hydrolysis, by DNA damaging agents or by base exci-
sion repair pathways (McClendon and Osheroff, 2007). 
In spite of the well demonstrated mutagenic activity of 
the intercalating agents and/or topoisomerase II cata-
lytic inhibitors and topoisomerase II poisons in multiple 
prokaryotic and eukaryotic systems, and despite the 
well documented clastogenic and cytotoxic effects of 
acridines and their amino derivatives (Rank et al., 2002), 
so far these compounds have been rarely tested in 
plants. 
Intercalating agents and/or topoisomerase inhibitors 
and topoisomerase poisons have been used to induce 
mutants in bacteria, blue-green algae, Chlamydomonas, 
fish, animal and human cell lines, Oenothera chloro-
plasts, etc. However, to the best of our knowledge 
(except for a report of male sterile mutants induced 
by acriflavine and ethidium bromide in sugar beet) no 
other major publication has been produced reporting 
the use of this kind of compound for plant mutagenesis. 
The strong ability to induce frameshift mutations, DSBs 
and other types of mutational events, in some cases 
mediated by adduct formation, provides compelling 
reasons for more studies in plant systems. They might 
also become a new type of mutagen that can induce 
unique mutations for plant molecular biologists, e.g. for 
TILLING experiments, and for plant breeders.
Treatments with these mutagens are usually performed 
with low micro-molar solutions prepared from 5–10 mg/
ml stock solutions in dimethylsulphoxide (DMSO), 10 
mM HCl, 10mM KOH or in water. Optimal concentra-
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tions and exposure times for plant mutation breeding 
purposes need to be determined. Although plant muta-
genic treatments using these compounds can be per-
formed on seeds, it is to be expected that compounds 
with mutagenic effects associated with topoisomerase 
poisoning or topoisomerase inhibition activities will be 
more effective on vegetatively growing tissues, particu-
larly on seedlings and in vivo and in vitro explants. 
5. The Resurgence of Chemical Mutagenesis 
and Practical Tips
5.1. Resurgence of Chemical Mutagenesis
The mutagenicity of alkylating agents was largely deter-
mined by I. Rapoport and co-workers, and readers 
able to read Russian can find an enormous amount of 
relatively old literature reporting a panoply of induced 
mutations in a wide range of biological subjects, 
including plants. However, the most important sources 
of literature on plant chemical mutagenesis are the 
discontinued Mutation Breeding Newsletter and its suc-
cessor, the Plant Breeding & Genetics Newsletter, as well 
as the proceedings of meetings and other literature 
edited by the IAEA. Another good source of informa-
tion on chemically induce mutants are the “newsletters” 
edited by International Societies for specific crops, e.g. 
pea and barley, as well as web pages and information 
published by germplasm centres and curators, e.g. John 
Innes Institute, UK. 
In recent years, experimental mutagenesis has re-
emerged as an important tool for plant reverse and 
forward genetics. Large mutagenized plant populations 
are produced and used to screen both for induced 
phenotypically expressed mutations and for mutational 
changes in specific genomic sequences using a proce-
dure commonly called TILLING (targeting induced local 
lesions in genomes, see Chapters 21 and 22). Although 
physical mutagenic agents such as gamma radiation 
and fast neutrons and other mutagens such as sodium 
azide (NaN3) have been used to produce mutant popu-
lations for TILLING analyses, the alkylating agents, in 
particular EMS but also MNU, are the most frequently 
utilized mutagens for that purpose. As a consequence 
there has been a resurgence of mainstream articles and 
references to plant chemical mutagenesis. 
5.2. Practical Tips for Plant Mutagenesis 
 Experiments
The guide lines below were developed for working 
with strong mutagens and carcinogens such as alkylat-
ing agents, but may be followed when using muta-
gens assumed to be less toxic, less mutagenic or less 
carcinogenic. 
1. Alkylating agents are very toxic and very strong 
mutagens and carcinogens. This should always 
be kept in mind when handling these substances, 
health and safety should be the first consideration.
2. Handling chemical mutagens is relatively safe if 
safety rules are strictly observed.  It is worth men-
tioning that handling chemical mutagens with 
excessive fear can be dangerous.  Fear overcomes 
rational behaviour and the risk of accidents (usually 
minor) increases.
3. Lab coats and gloves are absolutely mandatory 
when handling chemical mutagens.  Protective eye 
covers are also mandatory in all operations not per-
formed behind the protection of a fume hood front 
glass or other protected cabinet.
4. Vials containing alkylating agents should always 
be opened in a fume hood or other specialized 
containment facility due the possibility of toxic gas 
formation, sometimes under pressure.
5. Gloves do not protect completely from mutagenic 
solutions and should never be in contact with the 
compound, either solid or in solution.  Gloves 
should be changed frequently and disposed of in a 
specific designated bag.
6. The weighing of solid alkylating agents should be 
done as quickly as possible, but not in a rush. The 
required amount should be calculated.  As soon as 
a quantity close to the needed amount is reached 
weighing must be stopped. The final concentration 
of the solution can be corrected adding the appro-
priate amount of water or buffer. 
7. Weighing can be avoided using pre-weighed muta-
gens in sealed bottles. Solid mutagens such as MNU 
or ENU can be acquired in ISOPAC vials to which 
solvents (buffer, DMSO, ethanol) can be added via 
injection through a resealable cap.  
8.  Solutions are safer to handle than substances in 
a powder/solid form. Liquid spills are also much 
easier to locate than small powder particles. When 
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weighing an alkylating agent it is advisable to add 
some millilitres of the solvent (DMSO, ethanol) 
immediately after weighing out the material – this 
will prevent further dispersal of the powder and will 
retain any liberated gas. It is also advisable that any 
tool (e.g. spatula) that has been in contact with the 
mutagen is immersed immediately in a solvent.
9. All surfaces, over which mutagens are supposed 
to be manipulated (space around balances, fume 
hood, etc.), can be covered with filter paper fixed 
with tape or other means. At the end of the treat-
ment the paper can be carefully removed trapping 
any spilled particles or drops and disposed of in a 
specific designated disposal bag.
10. After the mutagen is dissolved in an adequate amount 
of buffer or water, the solution can be poured over 
the plant material to be treated.  Plant materials 
that can cause splashes (seeds, tubers, corms, etc.) 
should first be placed into the container used for 
treatment (e.g. a simple glass beaker). Alternatively, 
the plant material can be immersed in the final 
volume of water or buffer solution to which the 
mutagen dissolved in a solvent (DMSO, ethanol) can 
be added with careful stirring (e.g. with a glass rod). 
During the mutagenic treatment containers, even in 
a fume hood, should be covered, e.g. by parafilm. 
11. After pre-soaking, if the remaining water or buffer 
is removed, the amount of liquid taken up by the 
plant materials should be taken into account if an 
exact calculation of the final concentration of the 
mutagen is required. 
12. At the end of the treatment period the mutagenic 
solution should be decanted or pipetted out, or 
the treated material removed from the mutagenic 
solution (easier for cuttings, tubers, corms, etc.). In 
both cases treated plant material should be washed 
immediately with water to remove the remain-
ing mutagenic solution. After this, three or more 
changes of water should be used for at least one 
hour in order to remove as much of the mutagen 
as possible.
13. Immersion of the plant material in 10% sodium 
thiosulphate solution for a few minutes can help to 
inactivate the mutagenic agent.
14. Mutagenized plant material to be carried forward 
for in vitro culture needs to be surface sterilized 
after the mutagenic treatment.
15. Workers engaged in sowing, planting, grafting or 
in vitro culture of mutagenized material should be 
fully informed about the material they are manipu-
lating. Careful supervision of workers is required 
to ensure that they wear appropriate protective 
clothing and gloves and that mutagenized materials 
are not manipulated directly by hand (even when 
wearing gloves). Direct contact with the treated 
material should be avoided; forceps can be used 
when sowing and planting and additional protec-
tion is necessary when preparing scions to reduce 
the risk of contact with the mutagen still in the plant 
material. 
16. Chemical mutagenic treatments should always be 
performed by, or under the directed supervision 
of a specially trained officer to avoid contamina-
tions and/or non-declared and non-eliminated 
contaminations.
17. Treatments can be performed in specialized labo-
ratories or in common laboratories. In the last case, 
access to treatment rooms should be restricted. 
Formation of toxic gases (e.g. diazoalkanes from 
nitroso compounds at high pH) and their transpor-
tation to other laboratories via fume hood conduits 
should be avoided completely. Is advisable to per-
form mutagenic treatments out of regular working 
time.
18. Mutagenic solutions, including waste waters, 
should be inactivated and glassware and metal-
lic instruments (spatula, forceps, etc.) chemically 
decontaminated. Plastics, paper, gloves, etc. 
should be incinerated (Box 12.2).  Most commonly 
used alkylating agents can be inactivated by adding 
sodium thiosulphate solution (10% final concen-
tration) to the mutagenic solution and mutagenic 
waste liquids, and by slowly increasing the pH using 
a sodium hydroxide solution or sodium hydroxide 
pellets (to 1% final concentration) and kept at least 
overnight to decompose. This will assure the com-
plete inactivation of the mutagens.
A solution of 10% sodium thiosulphate and 1% sodium 
hydroxide, should be used for decontamination of 
glassware and disposable labware.  Information regard-
ing inactivation and disposal of specific mutagens can 
be found at http://toxnet.nlm.nih.gov/.
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6.2. Websites
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